September 2004

J Psychiatry Neurosci 2004;29(5)

Editorial

Ethical conduct of journal editors
S.N. Young, R.T. Joffe

Commentary

Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
M.D. Berry

Review Papers

Implication des gènes du système sérotoninergique dans la vulnérabilité aux conduites suicidaires
P. Courtet, F. Jollant, D. Castelnau, B. Astruc, C. Buresi, A. Malafosse

Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humans
C.D. Walker, S. Deschamps, K. Proulx, M. Tu, C. Salzman, B. Woodside, S. Lupien, N. Gallo-Payet, D. Richard

Research Paper

Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
M. Gitlin, L.L. Altshuler, M.A. Frye, R. Suri, E.L. Huynh, L. Fairbanks, M. Bauer, S. Korenman

CCNP News and Views

American Psychiatric Association honours founding member of the Canadian College of Neuropsychopharmacology

Psychopharmacology for the Clinician

With all the recent concern about SSRIs and suicidality, what advice should be given to the practising clinician regarding the management of a depressed young person?
Y.D. Lapierre